生物防御市场规模、份额及成长分析（按产品、应用、最终用户及地区划分）－2026-2033年产业预测

预计到 2024 年，全球生物防御市场规模将达到 152.9 亿美元，到 2025 年将达到 162.4 亿美元，到 2033 年将达到 262.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 6.2%。

由于政府主导力度加大、投资增加以及对生物防御策略的高度重视，全球生物防御市场正经历显着成长。人们对流感、兹卡和伊波拉出血热等感染疾病的日益关注，进一步凸显了采取强有力的生物防御措施的迫切性。基因工程和生物技术的进步使得改造致命病毒成为可能，因此全面的防御措施至关重要。随着生物威胁在全球日益普遍，生物防御对国家安全仍然至关重要。过去涉及炭疽菌等病原体的生物恐怖攻击事件凸显了这些威胁的经济影响，促使各国政府制定了各种法规和条约。专注于感染疾病诊断和治疗的机构正在进行的研究，进一步支持了有效应对潜在生物攻击的措施的开发，从而强化了生物防御准备的重要性。

全球生物防御市场驱动因素

全球生物防御市场主要由联邦和州政府为加强国家和公共卫生安全而进行的大量投资所驱动。这些财政投入对于疫苗、诊断和治疗方法的研发至关重要，确保医疗卫生系统能够充分应对生物威胁。此外，政府在紧急时应对计画和培训方面的支出，也为创新生物防御解决方案的推进创造了有利环境。这项具有前瞻性的措施最终增强了抵御潜在生物攻击和流行病的能力，凸显了有效生物防御策略在保护公众健康方面的关键作用。

限制全球生物防御市场的因素

全球生物防御市场面临严峻挑战，现有企业之间的激烈竞争是造成此局面的主要原因。这种竞争导致价格战和利润率下降，为新进入者设置了重重障碍。市场主导企业利用其雄厚的资源和与监管机构的密切关係，实施激进的定价策略以维持其市场地位。这些策略不仅挤压了利润空间，也扼杀了小型企业的成长潜力，最终阻碍了这个对公共卫生和安全至关重要的领域的创新和竞争。

全球生物防御市场趋势

在全球基因组学和生物技术进步的推动下，全球生物防御市场正经历着向个人化医疗的重大转变。这一趋势强调开发针对特定生物威胁和不同人群独特基因特征的客製化疫苗和治疗方法。个人化医疗能够更精准、更有效率地应对感染疾病，进而提升生物防御策略的效用。随着技术的进步，高效、针对特异性族群的疫苗的潜力日益增强，这进一步凸显了开发能够解决个人脆弱性和社区健康问题的适应性医疗解决方案的必要性。这有可能重塑全球生物防御格局。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术分析

全球生物防御市场规模（依产品划分）及复合年增长率（2026-2033 年）

• 疫苗
  • 炭疽菌
  • 天花
  • 肉毒桿菌中毒
  • 其他的
• 威胁侦测设备
  • 采样装置
  • 探测器/执行器
  • 识别装置
  • 检测方法和试剂

全球生物防御市场规模（依应用领域及复合年增长率划分）（2026-2033 年）

• 军队
• 私部门

全球生物防御市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院和诊所
• 门诊治疗中心
• 其他的

全球生物防御市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Emergent BioSolutions Inc.（United States）
• SIGA Technologies, Inc.（United States）
• Dynavax Technologies Corporation（United States）
• Altimmune Inc.（United States）
• XOMA Corporation（United States）
• Cleveland BioLabs Inc.（United States）
• Ichor Medical Systems, Inc.（United States）
• ANP Technologies, Inc.（United States）
• PositiveID Corporation（United States）
• Alexeter Technologies LLC（United States）
• BioFire Defense（bioMerieux SA）（United States）
• Elusys Therapeutics Inc.（United States）
• Battelle National Biodefense Institute, LLC（United States）
• Gryphon Scientific LLC（United States）
• BioRisk Reduction（United States）
• CBRNe Science and Consequence Management World Congress（United States）
• Mammoth Biosciences（United States）
• Alnylam Pharmaceuticals Inc.（United States）
• Bruker Detection（United States）
• New Horizon Diagnostic Corp.（United States）

结论与建议

Global Biodefense Market size was valued at USD 15.29 Billion in 2024 and is poised to grow from USD 16.24 Billion in 2025 to USD 26.27 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).

The global biodefense market is experiencing significant growth due to heightened government initiatives and increased investments, alongside a strong emphasis on biodefense strategies. Rising concerns over infectious diseases such as flu, Zika, and Ebola enhance the urgency for robust biodefense measures. Advances in genetic engineering and biotechnology enable the modification of lethal viruses, necessitating comprehensive defenses. With biological threats prevalent worldwide, biodefense remains crucial for national security. Historical instances of bioterrorism using agents like anthrax underscore the financial impact of such threats, prompting governments to establish various statutes and treaties. Ongoing research by institutions focused on diagnosing and treating infectious diseases further aids in developing effective responses to potential biological attacks, reinforcing the importance of biodefense preparedness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biodefense market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segments Analysis

Global Biodefense Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Vaccines and Biothreat Detection Devices. Based on Application, the market is segmented into Military and Civilian. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biodefense Market

The Global Biodefense market is significantly fueled by the substantial investments made by federal and state governments aimed at enhancing national and public health security. These financial commitments are essential for the development of vaccines, diagnostics, and treatments, ensuring that healthcare systems are adequately prepared to confront biological threats. Furthermore, government expenditures on emergency planning infrastructure and training create an environment conducive to the advancement of innovative biodefense solutions. This proactive approach ultimately fosters resilience against potential biological attacks or pandemics, highlighting the critical importance of effective biodefense strategies in safeguarding public health.

Restraints in the Global Biodefense Market

The Global Biodefense market faces significant challenges due to intense competition among established companies. This rivalry can result in price wars and reduced profit margins, creating barriers for new entrants attempting to penetrate the market. Dominant players benefit from abundant resources and well-established connections with regulatory authorities, allowing them to implement aggressive pricing strategies to maintain their market positions. Such tactics not only compress profit margins but also hinder the growth potential of smaller firms, ultimately stifling innovation and competition within this critical sector that is essential for public health and safety.

Market Trends of the Global Biodefense Market

The Global Biodefense market is experiencing a significant shift towards personalized medicine, driven by advancements in genomics and biotechnology. This trend emphasizes the development of customized vaccines and treatments tailored to address specific biological threats and the unique genetic profiles of various populations. Personalized medicine enhances the efficacy of biodefense strategies by enabling more precise and efficient responses to infectious diseases. As technologies evolve, the potential for highly effective, population-specific vaccines increases, reinforcing the need for adaptive health solutions that cater to individual vulnerabilities and regional health concerns, which is poised to redefine the landscape of biodefense initiatives globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Biodefense Market Size by Product & CAGR (2026-2033)

• Market Overview
• Vaccines
  • Anthrax
  • Smallpox
  • Botulism
  • Others
• Biothreat Detection Devices
  • Samplers
  • Detectors/Triggering Devices
  • Identifiers
  • Assays and Reagents

Global Biodefense Market Size by Application & CAGR (2026-2033)

• Market Overview
• Military
• Civilian

Global Biodefense Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Global Biodefense Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Emergent BioSolutions Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGA Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XOMA Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland BioLabs Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ichor Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANP Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PositiveID Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alexeter Technologies LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioFire Defense (bioMerieux SA) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elusys Therapeutics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Battelle National Biodefense Institute, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gryphon Scientific LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioRisk Reduction (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CBRNe Science and Consequence Management World Congress (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alnylam Pharmaceuticals Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Detection (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New Horizon Diagnostic Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations